A Study of CSTI-500 in Patients With Prader-Willi Syndrome
NCT07348601
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Prader-Willi Syndrome
Interventions
DRUG:
CSTI-500
Sponsor
ConSynance Therapeutics